Di Chiara C, Papenburg J, Bettinger JA, Farrar DS,. Epidemiology and severity of pediatric influenza hospitalizations before and during the COVID-19 pandemic: a surveillance study of the Canadian immunization monitoring program (IMPACT), 2012-2023. Lancet Reg Health Am. 2026 Jun 6;61:101525
Background: The COVID-19 pandemic disrupted respiratory virus circulation, including influenza. We described trends in seasonality, demographics, and severity of pediatric influenza hospitalizations in Canada before and during the pandemic.
Methods: We conducted national prospective surveillance through the Canadian Immunization Monitoring Program, ACTive (IMPACT), across 12 tertiary-care pediatric centers. Children <17 years hospitalized with laboratory-confirmed influenza between August 2012-August 2023 were included. Periods were categorized as pre-pandemic (2012-March 2020), and pandemic (2021-2022, 2022-2023). Severe disease was defined as intensive care unit (ICU) admission, mechanical ventilation, extracorporeal membrane oxygenation, and/or death. Adjusted odds ratios (aOR) were estimated using multivariable logistic regression.
Findings: Among 10,091 hospitalizations, 7938 occurred pre-pandemic (annual average = 955), 335 in 2021-2022, and 1810 in 2022-2023. The median age was 3.0 (IQR 1.2-6.4) in pre-pandemic, 3.3 (IQR 1.4-7.3) in 2021-2022, and 3.8 years (IQR 1.7-7.2, p < 0.001) in 2022-2023. ICU admissions declined in 2021-2022 (11.3%) and rose in 2022-2023 (15.9%), though remaining below pre-pandemic levels (17.3%). Mortality was stable across periods (0.6%). The odds of severe disease were lower in 2021-2022 (aOR 0.63, 95% CI 0.44-0.89) and 2022-2023 (aOR 0.85, 95% CI 0.74-0.98) compared to pre-pandemic.
Interpretation: Pediatric influenza hospitalizations nearly doubled in 2022-2023, with a modest shift in age distribution toward older children. Although severity indicators rose compared to 2021-2022, they remained slightly reduced compared to pre-pandemic seasons, suggesting suggest a partial return toward pre-pandemic epidemiologic patterns.
Methods: We conducted national prospective surveillance through the Canadian Immunization Monitoring Program, ACTive (IMPACT), across 12 tertiary-care pediatric centers. Children <17 years hospitalized with laboratory-confirmed influenza between August 2012-August 2023 were included. Periods were categorized as pre-pandemic (2012-March 2020), and pandemic (2021-2022, 2022-2023). Severe disease was defined as intensive care unit (ICU) admission, mechanical ventilation, extracorporeal membrane oxygenation, and/or death. Adjusted odds ratios (aOR) were estimated using multivariable logistic regression.
Findings: Among 10,091 hospitalizations, 7938 occurred pre-pandemic (annual average = 955), 335 in 2021-2022, and 1810 in 2022-2023. The median age was 3.0 (IQR 1.2-6.4) in pre-pandemic, 3.3 (IQR 1.4-7.3) in 2021-2022, and 3.8 years (IQR 1.7-7.2, p < 0.001) in 2022-2023. ICU admissions declined in 2021-2022 (11.3%) and rose in 2022-2023 (15.9%), though remaining below pre-pandemic levels (17.3%). Mortality was stable across periods (0.6%). The odds of severe disease were lower in 2021-2022 (aOR 0.63, 95% CI 0.44-0.89) and 2022-2023 (aOR 0.85, 95% CI 0.74-0.98) compared to pre-pandemic.
Interpretation: Pediatric influenza hospitalizations nearly doubled in 2022-2023, with a modest shift in age distribution toward older children. Although severity indicators rose compared to 2021-2022, they remained slightly reduced compared to pre-pandemic seasons, suggesting suggest a partial return toward pre-pandemic epidemiologic patterns.
See Also:
Latest articles in those days:
- Host Species Contribution to the Spatiotemporal Dynamics of the 2024-2025 H5N1 Epidemic in Italy 13 hours ago
- mRNA-based influenza vaccine expands the B cell response breadth in humans 13 hours ago
- Molecular surveillance and predictive risk modelling of avian influenza virus in wild birds in Egypt 13 hours ago
- Germany as a key transit hub for the emergence and spread of high pathogenicity avian influenza H5 clade 2.3.4.4b reassortants in Europe 2 days ago
- Degradation of ACSL3 by influenza A virus shifts unfolded protein response from antiviral defense to viral evasion 2 days ago
[Go Top] [Close Window]


